GovChime
Notice ID: ecb50bfe400ea6bdd4d1276e29a233b9Combined Synopsis/Solicitation

66--VA249-18-AP-5995 BacT/Alert 3D Control Module (Reagent) - Base +4

Archived on January 6, 2019. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
12:00 AM UTC−05:00
Posted
November 26, 2018
Notice type
Combined Synopsis/Solicitation
NAICS
325413: In-Vitro Diagnostic Substance Manufacturing

Notice details

Place of performance
Department of Veterans Affairs;James H. Quillen VA Medical Center;Corner of Lamont & Veterans Way;Mountain, Home, TN 37684 USA
PSC
66: INSTRUMENTS AND LABORATORY EQPT
Last updated
Dec 6, 2025

Identifiers

Solicitation number
36C24919Q0036
Notice ID
ecb50bfe400ea6bdd4d1276e29a233b9

Description

Combine Synopsis/Solicitation General Information Document Type: Combined Solicitation/Synopsis Solicitation Number: 36C24919Q0036 Posted Date: 11/16/2018 Response Date: 12/07/2018 Product or Service Code: 6603 NAICS Code: 325413 Contracting Office Address NCO 9 ATTN: Chaz Bowling Department of Veterans Affairs Contracting Office, 4th Floor 1639 Medical Center Parkway Murfreesboro, TN 37129 Description This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested, and a written solicitation document will not be issued. This solicitation is a request for quotations. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-101/10-26-2018 The associated North American Industrial Classification System (NAICS) code for this procurement is 325413, with a small business size standard of 1250 employees. The Network Contracting Office 9 is seeking a vendor that will provide the necessary requirement for the James H. Quillen VA Medical Center. All questions regarding this RFQ must be in writing and may be sent by e-mail to Chaz.Bowling@va.gov Questions must be received no later than November 28, 2018 3:30PM CST. No further question will be accepted after that date and time. BRAND NAME OR EQUAL All interested companies shall provide quotations for the following Brand Name or Equal requirement outlined in the Schedule below: Schedule CLIN Description Quantity Unit Price Total Price Base Year POP 1/1/2019 12/31/2019 0001 Equipment Part Number - 4700216 SYS-VITEK 2 0060 Base Year Period of Performance 1/1/2019-12/31/2019 1 0002 Item Number - 21341 GN Test Kit VTK2 Base Year Period of Performance 1/1/2019-12/31/2019 170 Boxes 0003 Item Number 21342 GN Test Kit VTK2 Base Year Period of Performance 1/1/2019-12/31/2019 80 Boxes 0004 Item Number 21343 YST Test Kit VTK2 Base Year Period of Performance 1/1/2019-12/31/2019 12 Boxes 0005 Item Number - 21347 ANC ID Base Year Period of Performance 1/1/2019-12/31/2019 12 Boxes 0006 Item Number AST-GN-GP Vitek 2 GN and GP AST Cards Base Year Period of Performance 1/1/2019-12/31/2019 200 Boxes 0007 Equipment Part Number - 4700109 Option Year One Period of Performance 1/1/2019-12/31/2019 1 0008 Item Number - 259789 BacT/Alert SA Base Year Period of Performance 1/1/2019-12/31/2019 50 Cases 0009 Item Number - 259790 BacT/Alert SA Base Year Period of Performance 1/1/2019-12/31/2019 50 Cases Total Amount $ Option Year One POP 1/1/2020 12/31/2020 1001 Equipment Part Number - 4700216 SYS-VITEK 2 0060 Option Year One Period of Performance 1/1/2020-12/31/2020 1 1002 Item Number - 21341 GN Test Kit VTK2 Option Year One Period of Performance 1/1/2020-12/31/2020 170 Boxes 1003 Item Number 21342 GN Test Kit VTK2 Option Year One Period of Performance 1/1/2020-12/31/2020 80 Boxes 1004 Item Number 21343 YST Test Kit VTK2 Option Year One Period of Performance 1/1/2020-12/31/2020 12 Boxes 1005 Item Number - 21347 ANC ID Option Year One Period of Performance 1/1/2020-12/31/2020 12 Boxes 1006 Item Number AST-GN-GP Vitek 2 GN and GP AST Cards Option Year One Period of Performance 1/1/2020-12/31/2020 200 Boxes 1007 Equipment Part Number - 4700109 Option Year One Period of Performance 1/1/2020-12/31/2020 1 1008 Item Number - 259789 BacT/Alert SA Option Year One Period of Performance 1/1/2020-12/31/2020 50 Cases 1009 Item Number - 259790 BacT/Alert SA Option Year One Period of Performance 1/1/2020-12/31/2020 50 Cases Total Amount $ Option Year Two 1/1/2021 - 12/31/2021 2001 Equipment Part Number - 4700216 SYS-VITEK 2 0060 Option Year Two Period of Performance 1/1/2021-12/31/2021 1 2002 Item Number - 21341 GN Test Kit VTK2 Option Year Two Period of Performance 1/1/2021-12/31/2021 170 Boxes 2003 Item Number 21342 GN Test Kit VTK2 Option Year Two Period of Performance 1/1/2021-12/31/2021 80 Boxes 2004 Item Number 21343 YST Test Kit VTK2 Option Year Two Period of Performance 1/1/2021-12/31/2021 12 Boxes 2005 Item Number - 21347 ANC ID Option Year Two Period of Performance 1/1/2021-12/31/2021 12 Boxes 2006 Item Number AST-GN-GP Vitek 2 GN and GP AST Cards Option Year Two Period of Performance 1/1/2021-12/31/2021 200 Boxes 2007 Equipment Part Number - 4700109 Option Year Two Period of Performance 1/1/2021-12/31/2021 1 2008 Item Number - 259789 BacT/Alert SA Option Year Two Period of Performance 1/1/2021-12/31/2021 50 Cases 2009 Item Number - 259790 BacT/Alert SA Option Year Two Period of Performance 1/1/2021-12/31/2021 50 Cases Total Amount $ Option Year Three POP 1/1/2022 12/31/2022 3001 Equipment Part Number - 4700216 SYS-VITEK 2 0060 Option Year Three Period of Performance 1/1/2022-12/31/2022 1 3002 Item Number - 21341 GN Test Kit VTK2 Option Year Three Period of Performance 1/1/2022-12/31/2022 170 Boxes 3003 Item Number 21342 GN Test Kit VTK2 Option Year Three Period of Performance 1/1/2022-12/31/2022 80 Boxes 3004 Item Number 21343 YST Test Kit VTK2 Option Year Three Period of Performance 1/1/2022-12/31/2022 12 Boxes 3005 Item Number - 21347 ANC ID Option Year Three Period of Performance 1/1/2022-12/31/2022 12 Boxes 3006 Item Number AST-GN-GP Vitek 2 GN and GP AST Cards Option Year Three Period of Performance 1/1/2022-12/31/2022 200 Boxes 3007 Equipment Part Number - 4700109 Option Year Three Period of Performance 1/1/2022-12/31/2022 1 3008 Item Number - 259789 BacT/Alert SA Option Year Three Period of Performance 1/1/2022-12/31/2022 50 Cases 3009 Item Number - 259790 BacT/Alert SA Option Year Three Period of Performance 1/1/2022-12/31/2022 50 Cases Total Amount $ Option Year Four POP 1/1/2023 12/31/2023 4001 Equipment Part Number - 4700216 SYS-VITEK 2 0060 Option Year Four Period of Performance 1/1/2023-12/31/2023 1 4002 Item Number - 21341 GN Test Kit VTK2 Option Year Four Period of Performance 1/1/2023-12/31/2023 170 Boxes 4003 Item Number 21342 GN Test Kit VTK2 Option Year Four Period of Performance 1/1/2023-12/31/2023 80 Boxes 4004 Item Number 21343 YST Test Kit VTK2 Option Year Four Period of Performance 1/1/2023-12/31/2023 12 Boxes 4005 Item Number - 21347 ANC ID Option Year Four Period of Performance 1/1/2023-12/31/2023 12 Boxes 4006 Item Number AST-GN-GP Vitek 2 GN and GP AST Cards Option Year Four Period of Performance 1/1/2023-12/31/2023 200 Boxes 4007 Equipment Part Number - 4700109 Option Year Four Period of Performance 1/1/2023-12/31/2023 1 4008 Item Number - 259789 BacT/Alert SA Option Year Four Period of Performance 1/1/2023-12/31/2023 50 Cases 4009 Item Number - 259790 BacT/Alert SA Option Year Four Period of Performance 1/1/2023-12/31/2023 50 Cases Total Pricing $ Total Price of Base Plus Options $ Statement of Work (CLINs 0001-0006 and the subsequent option year CLINs) REQUIREMENT: This is a Brand Name or Equal requirement for the James H. Quillen VA Medical Center that requires a Cost Per Reportable Result (CPRR) Vitek 2 system and applicable reagents. This requirement is for a period of one year: January 1, 2019 - December 31, 2019, with an additional (4) four (1) one-year options. PURPOSE: The purpose of this agreement is for the Contractor to provide the James H Quillen VAMC Microbiology Lab with standardized microbiological system for the identification and sensitivity of microorganisms which shall have the capability of performing or reporting the clinical parameters as defined for the James H Quillen VAMC, Mountain Home, TN in accordance with the terms and conditions stated herein. The instruments shall be able to simultaneously perform the complete profile as described below and meet the performance characteristics for accuracy and precision as defined by the 1988 Clinical Laboratory Improvement Act (CLIA) and the Clinical and Laboratory Standards Institute (CLSI). The Contractor shall propose the suggested/recommended equipment/reagents for all sites that meet the requirements of the facility. PRICES AND TERMS: James H Quillen VAMC estimates the bacteria identification and susceptibility card volume of 783 month (9,480 cards/year). The Government estimates the volumes listed, but does not guarantee volumes as listed; they are ESTIMATES ONLY. TERM OF AGREEMENT: The agreement shall be effective for one year beginning January 1, 2019 December 31, 2019, with an additional (4) four (1) one-year options available. ORDERING METHOD: The participating facility will order products via telephone, facsimile or other written communication, identifying the products by number, quantity, address for delivery, and any special instructions. These items will be ordered as needed during the period of performance. DELIVERY TICKETS: Unless otherwise agreed to, all deliveries under this agreement shall be accompanied by delivery tickets or sales slips that shall contain the following information as a minimum: a. Name of contractor b. Contract number c. Model number or National Stock Number (NSN) d. Purchase order number e. Date of purchase f. Quantity, unit price and extension of each item (unit prices and extensions need not be shown when incompatible with the use of automated systems, provided that the invoice is itemized to show information) g. Date of shipment. INVOICES AND PAYMENTS: The Contractor shall invoice each delivery order as directed by the ordering activity. Payments will be made by the VA Finance Center, Austin, Texas. Invoices will be submitted electronically. INVENTORY AND SUPPLIES: a. Delivery of supplies: Any unexpected changes in methodology/technology shall be at the expense of the Contractor. b. Alert/Notification of delays in shipments as well as all technical advisory/recalls/alerts, prior to or simultaneously with field alerts shall be forwarded to the microbiology supervisor, lab chief, and the VISN 9 clinical systems program office manager. c. Special handling for emergency orders of supplies: In the event that the consumables are found to be defective and unsuitable for use with the contractor s equipment, or the contractor has failed to comply with the requirements for routing supply delivery, the contractor is required to deliver the consumable supplies within 24 hours of receipt of a verbal order for priority delivery from the government activity. If either circumstance has occurred, the contractor will deliver to the government site in the most expeditious manner possible without additional cost to the government GENERAL REQUIREMENTS: The system shall provide self-contained, fully automated identification and antibiotic susceptibility testing system for aerobic, facultative, fastidious, and anaerobic microorganisms and yeasts. The system shall have a data management system with varied options for analysis and reporting/review of cumulative patient data on organisms isolated and antimicrobial profiles, and allow for manual modification of susceptibility breakpoints to comply with new CLSI guidelines until such time that the vendor applies necessary software updates. The system shall have battery backup capable of maintaining data for at least 24 hours in the event of a facility power failure. The vendor shall provide hardware/software upgrades necessary to maintaining the integrity of the system at no additional charge to the government. These must be provided as they become available and as they are being offered to commercial customers. Changes in CLSI guidelines shall be implemented into the software upgrades in a timely manner. The vendor shall provide to each facility a copy of operating procedures in Clinical and Laboratory Standards Institute (CLSI) digital format at time of installation using software compatible with VA (Microsoft Office WORD). Interfacing: Instrumentation proposed shall be capable of bi-directional, bar-coded, computer interface with VistA (at a minimum shall be capable of downloading patient demographics from host computer, integrating this information with test results and uploading to the host computer). The system shall also offer independent, manual processing and printing of a chartable result in the event of LIS downtime. A printer for the analyzer shall be provided by the Contractor. Ancillary Equipment and Supplies: The Contractor shall provide, install and maintain, as indicated, any and all ancillary support equipment, consumables/supplies, parts and accessories necessary to fully operate the bacterial and susceptibility analyzer as defined in these specifications, e.g., McFarland standards, cabinetry to support/house the analyzer (if necessary) and universal interface equipment, Uninterruptible Power Supply (UPS) capable of supporting the full scope of equipment operation with a built-in line conditioner, for each proposed analyzer. The Contractor shall include all ancillary components that are customarily sold or provided with the model of equipment proposed, e.g. starter kits, tables/stands, etc. Maintenance and Repair: The Contractor shall be able to provide emergency equipment repair and preventative maintenance and any incremental support equipment, e.g. water system, offered according to the following terms: A technical assistance or support center shall be available by telephone hot-line 24/7 days/week with a maximum call back response time of 1 hour with on-site service provided, not to exceed 24 hours following determination that site service is required The technical assistance center shall be staffed with personnel who are fluent in English without the use of an interpreter. Ability to provide equipment service on a 24-hour/day 7 days/week basis for hospital-based systems. Scheduled preventative maintenance calls shall occur at a frequency to meet the minimum manufacturer s requirements to keep the equipment in optimal operating condition. Every notification for a repair service call shall be treated as a separate and new service call. During the term of the term of the contract, should the repair record of any individual piece of laboratory equipment reflect a downtime of 10% or greater of the normal working days in one calendar month, a determination will be made by the designated representative of the Government to replace the malfunctioning equipment with new equipment. The responsibility for maintaining the equipment furnished in good condition in accordance with manufacturer s instructions, shall be solely that of the contractor. The Government agrees to maintain the equipment according to manufacturer s specifications. Each instrument provided by the contractor shall maintain an uptime of 90% in each month of the term of the agreement. Training: The Contractor shall provide training on the operation of the system, data manipulation, preventative maintenance and basic trouble shooting and repair for 2 key operators. Any training program that involves off-site travel shall include the cost of airfare, room and board for each participant. A training or competency checklist shall be provided by the Contractor. Site Preparation: Site preparation specifications shall be furnished in writing by the Contractor as a part of the equipment quotation. These specifications shall be in such detail as to ensure that the equipment to be installed shall operate efficiently and conform to the manufacturer s claimed specifications. The Contractor shall be responsible for assessing the space available in each facility to ensure the right size equipment is provided; thereby not creating a safety hazard. Implementation and Transition: The Contractor shall provide with its quotation a transitioning plan for the complete transition of all services including installation and training of personnel, transition of all testing materials, reagents and supplies, etc., performance of all comparisons and validations. This transition shall be completed no later than 60 days after date of award. This timeline is based on a reasonable attempt of the Contractor to complete all of the necessary implementation requirements within the stated timeframe. Comparison and Validation of Analyzer: The Contractor shall perform at each site, to the satisfaction of the Government, at no cost to the Government all comparison and validation studies to include any linearity material and reagents needed for such correlation. The Contractor shall perform all statistical analysis and report data in an organized, clearly comprehensible format. This process shall be completed within two weeks of installation of the analyzer at each site and shall be consistent with current CLSI and related documents, College of American Pathologists (CAP) Standards, and Federal Regulations. Each model of fully automated identification and antibiotic susceptibility testing system offered shall comply with all general requirements stated herein. Each Contractor shall submit as part of their offer, technical data or descriptive literature to ascertain that the equipment offered meets the requirements outlined below. The Contractor shall provide FDA approved, self-contained, fully automated identification and antibiotic susceptibility testing system for aerobic, facultative, fastidious, and anaerobic microorganisms, and yeasts. Remanufactured or discontinued models are unacceptable for this agreement. The Contractor shall state the failure mean time (between failure and mean time to repair) for each piece of equipment offered. Emergency replacement of equipment shall be provided by the Contractor. TECHNICAL REQUIREMENTS: The system shall have a comprehensive and extensive data base of bacteria and yeast species that is consistent with CLSI guidelines. Vendor shall provide software upgrades at no charge to the government when CLSI guidelines change or are updated, or changes in bacterial nomenclature. The system shall offer a comprehensive array of bacterial antimicrobial susceptibility panels. Vendor shall supply a list of available susceptibility panels as well as a list of antibiotic exceptions for their methodology at time of proposal. The system shall offer detection of organisms that carry a carbapenems. The system shall be capable of producing an antibiogram of organisms by selected body sites. The system shall have a built-in quality control program to regularly monitor system performance. Statement of Work (CLINs 0007 0009 and the subsequent option year CLINs) REQUIREMENT: This is a Brand Name or Equal requirement for the James H. Quillen VA Medical Center that requires a Cost Per Reportable Result (CPRR) BacT/ALERT 3D 480 system and applicable reagents. This requirement is for a period of one year: January 1, 2019 - December 31, 2019, with an additional (4) four (1) one-year options. PURPOSE: The purpose of this requirement is for the contractor to provide the James H. Quillen VAMC, Mountain Home, TN Clinical Microbiology Lab with a microbiological blood culture system BacT/Alert, which shall have the capability of performing and reporting blood cultures in accordance with the terms and conditions stated herein. The instrument shall be able to simultaneously perform the complete blood culture as described below and meet the performance characteristics for accuracy and precision as defined by the 1988 Clinical Laboratory Improvement Act (CLIA) and the Clinical and Laboratory Standards Institute (CLSI). The instrument must be approved by the Food and Drug Administration (FDA). The Contractor shall propose the suggested/recommended equipment/reagents that meet the requirements of the facility. PRICES AND TERMS: James H Quillen VAMC estimates the blood culture volume of 580/month (13,920/year) each of both aerobic and anaerobic blood culture bottles. The Government estimates the volumes listed, but does not guarantee volumes as listed; they are ESTIMATES ONLY. TERM OF AGREEMENT: The agreement shall be effective for one year beginning January 1, 2019 December 31, 2019, with an additional (4) four (1) one-year options available. ORDERING METHOD: The participating facility will order products via telephone, facsimile or other written communication, identifying the products by number, quantity, address for delivery, and any special instructions. Items will be ordered as needed during the period of performance. DELIVERY TICKETS: Unless otherwise agreed to, all deliveries under this agreement shall be accompanied by delivery tickets or sales slips that shall contain the following information as a minimum: a. Name of contractor b. Contract number c. Model number or National Stock Number (NSN) d. Purchase order number e. Date of purchase f. Quantity, unit price and extension of each item (unit prices and extensions need not be shown when incompatible with the use of automated systems, provided that the invoice is itemized to show information) g. Date of shipment INVOICES AND PAYMENTS: The Contractor shall invoice each delivery order as directed by the ordering activity. Payments will be made by the VA Finance Center, Austin, Texas. Invoices will be submitted electronically. INVENTORY AND SUPPLIES: a. Delivery of supplies: Shall be in accordance with National FSS Statement of Work. Any unexpected changes in methodology/technology shall be at the expense of the Contractor. b. Alert/Notification of delays in shipments as well as all technical advisory/recalls/alerts, prior to or simultaneously with field alerts shall be forwarded to the microbiology supervisor, lab chief, and the VISN 9 clinical systems program office manager. c. Special handling for emergency orders of supplies: In the event that the consumables are found to be defective and unsuitable for use with the contractor s equipment, or the contractor has failed to comply with the requirements for routing supply delivery, the contractor is required to deliver the consumable supplies within 24 hours of receipt of a verbal order for priority delivery from the government activity. If either circumstance has occurred, the contractor will deliver to the government site in the most expeditious manner possible without additional cost to the government GENERAL REQUIREMENTS: (1) The system shall provide self-contained, continuous, computerized, automated monitoring of blood culture bottles with immediate, active (e.g. audible and visual alarm) notification of microorganism growth based upon preprogrammed criteria and notification of termination of maximum programmed incubation period when no microorganism growth is detected. (2) Blood culture bottle configurations (optimal and low volume samples) and formulations capable of maximizing growth potential of various microorganisms (e.g. aerobic and anaerobic bacteria and yeast) shall be available. (3) The system shall have sufficient capacity and throughput to meet the volume and service demands as defined in the Prices and Terms. The system should allow a minimum capacity of 480 bottles. (4) The system will be capable of processing inoculated bottles that have been incubated off line for up to 12 hours. (5) Blood culture bottles are the only ones on the market that are FDA cleared for blood and sterile body fluids. Blood culture bottles that are FDA approved for delayed entry . Up to 24 hours! Blood level detection on every bottle, this is a CAP Standard MIC 22640 compliant requirement. Automated loading, scanning and unloading, saving valuable skilled tech hours. Rapid Diagnostics and Rapid Detection. (10) The vendor shall provide hardware/software upgrades necessary to maintaining the integrity of the system at no additional charge to the government. These must be provided as they become available and as they are being offered to commercial customers. (11) Ancillary Equipment and Supplies: The Contractor shall provide, install and maintain, as indicated, any and all ancillary support equipment, consumables/supplies, parts and accessories necessary to fully operate the blood culture analyzer(s) as defined in these specifications, e.g., cabinetry to support/house the analyzer (if necessary), universal interface equipment, Uninterruptible Power Supply (UPS) capable of supporting the full scope of equipment operation with a built-in line conditioner, for each proposed analyzer. The Contractor shall include all ancillary components that are customarily sold or provided with the model of equipment proposed, e.g. starter kits, tables/stands, etc. (12) Maintenance and Repair: The Contractor shall be able to provide emergency equipment repair and preventative maintenance and any incremental support equipment, offered according to the following terms: (a) A technical assistance or support center shall be available by telephone hot-line 24/7 days/week with a maximum call back response time of 1 hour with on-site service provided, not to exceed 24 hours following determination that site service is required. The technical assistance center shall be staffed with personnel who are fluent in English without the use of an interpreter. (b) Ability to provide equipment service on a 24-hour/day 7 days/week basis for hospital-based systems. (c) Every notification for a repair service call shall be treated as a separate and new service call. (d) During the term of the contract, should the repair record of any individual piece of laboratory equipment reflect a downtime of 10% or greater of the normal working days in one calendar month, a determination will be made by the designated representative of the Government to replace the malfunctioning equipment with new equipment. The responsibility for maintaining the equipment furnished in good condition in accordance with manufacturer s instructions, shall be solely that of the contractor. The Government agrees to maintain the equipment according to manufacturer s specifications. Each instrument provided by the contractor shall maintain an uptime of 90% in each month of the term of the agreement. (e) Scheduled preventative maintenance calls shall occur at a frequency to meet the minimum manufacturer s requirements to keep the equipment in optimal operating condition. The company will be responsible for tracking and scheduling all preventive maintenance. This must conform to instrument specifications and all regulatory requirements. Documentation of the maintenance will be provided to the laboratory at the time of completion. This maintenance must be provided within 2 weeks of the recommended schedule. (f) The system must require minimal daily and periodic maintenance. The reading chambers must be modular in nature allowing for the isolation of a given problem without having to shut the entire system down. (13) Training: The Contractor shall provide training at the time of installation to include training on the operation of the system, data manipulation, preventative maintenance and basic trouble shooting and repair for 2 key operators. Any training program that involves off-site travel shall include the cost of airfare, room and board for each participant. A training or competency checklist shall be provided by the Contractor. (14) Site Preparation: Site preparation specifications shall be furnished in writing by the Contractor as a part of the equipment proposal. These specifications shall be in such detail as to ensure that the equipment to be installed shall operate efficiently and conform to the manufacturer s claimed specifications. The Contractor shall be responsible for assessing the space available in the facility in order to ensure the right size equipment is provided; thereby not creating a safety hazard. (15) Implementation and Transition: The Contractor shall provide with its quotation a transitioning plan for the complete transition of all services under the awarded agreement including installation and training of personnel, transition of all testing materials, reagents and supplies, etc., performance of all correlations and validations. This transition shall be completed no later than 120 days after the award of the agreement. This timeline is based on a reasonable attempt of the Contractor to complete all of the necessary implementation requirements within the stated timeframe. (16) Comparison and Validation of Analyzer: The Contractor shall assist, to the satisfaction of the Government, at no cost to the Government, all comparison and validation studies to include any materials and reagents needed for such correlation. The Contractor shall perform all of the statistical analysis and report data in an organized, clearly comprehensible format. This process shall be completed within two weeks of installation of the analyzer and shall be consistent with current CLSI (formerly NCCLS) and related documents, CAP Standards and Federal Regulations. (17) The vendor shall provide a copy of operating procedures in Clinical and Laboratory Standards Institute (CLSI) digital format at time of installation using software compatible with VA (Microsoft Office WORD). (18) Each model of blood culture analyzer offered shall comply with all general requirements stated herein. Each Contractor shall submit as part of their offer, technical data or descriptive literature to ascertain that the equipment offered meets the requirements outlined below. a. The Contractor shall provide FDA approved, automated blood culture monitoring system/analyzer. Remanufactured or discontinued models are unacceptable for this agreement. b. The Contractor shall state the failure mean time (between failure and mean time to repair) for each piece of equipment offered. Emergency replacement of equipment shall be provided by the Contractor. TECHNICAL REQUIREMENTS: Bar-code System: The system shall support bar-code recognition of inoculated bottles for tracking of bottles at entry into the system and throughout incubation until such time as the incubation has finalized as positive or negative for growth. Data Management System: Shall be able to support varied programmed bottle incubation periods from any selected culture from 5 days to 21 days. Shall be capable of maintaining a computerized log for detection time of positive growth of any bottle with an audible and visual alert system when positive growth is detected. Shall be capable of maintaining all data for up to 30 minutes in the event of normal electrical power interruptions via battery backup. Shall have a built-in quality control program to regularly monitor performance of vital components. The capability to record, store and print the following information: blood culture bottle location length of incubation time to detection growth curve analysis of positive vials required quality control and instrument maintenance information patient demographic information and specimen results Blood Culture Bottles: Shall be easily distinguished (e.g. color coded) for utility or intended purpose. Shall be approved for culture of normally sterile body fluids other than blood. Shall be bar-coded with unique identifiers for loading and system monitoring. Shall be formulated as not to require venting prior to incubation of aerobic bottles. Safety: The system must have sufficient safety features to avoid unnecessary exposure to bio-hazardous and chemical materials. The exposure to and the volume of bio-hazardous and chemical material generated by the equipment must be minimal and require a minimum amount of handling. Progress and Compliance: The system must perform blood cultures as advertised, and meet the performance characteristics for accuracy and precision as defined by the 1988 Clinical Laboratory Improvement Act (CLIA) and the Clinical and Laboratory Standards Institute (CLSI). ADDITIONAL REQUIRMENTS FOR ALL ITEMS SITE VISIT: If a site visit is required to provide an accurate quote in response to this solicitation then the contractor shall email chaz.bowling@va.gov to request one before November 23, 2018 so that the necessary arrangements can be m...

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:36C24919Q0036
  1. Combined Synopsis
  1. 2×
    Combined SynopsisCurrentNov 16, 2018

    66--VA249-18-AP-5995 BacT/Alert 3D Control Module (Reagent) - Base +4

    Notice ecb50bfe400ea6bdd4d1276e29a233b9 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Combined synopsis/solicitation for Immunoassay Reagents, Supplies and Consumables to be used for patient testing on an existing Architect i1000 analyzer located at the Pathology and Laboratory Medicine Services in Southern Arizona VA Medical Center (VA Tucson).
-Combined Synopsis11/13/2026
Boise, Idaho VAMC Transfusion Services requires red blood cell reagents that meet strict quality control and compliance standards for patient testing. These reagents are essential for safely matching donated blood products to recipients who need them for life-saving treatments—a process carried out exclusively in the Transfusion Services Department. The vendor is responsible for supplying quality control check cells as well as antibody identification panel cells to fulfill these requirements and support effective patient care. 5-year agreement. Base Year Period of Performance: 12/01/2026-11/30/2027. Four option years to follow based upon the Government's needs and discretion. Transfusion Medicine supports all major hospital departments, including Emergency, Surgery, Oncology, and Medical Units. Without a dedicated Transfusion Medicine Department, these units cannot operate effectively. Each VAMC needs its own department, as services are site-specific across the VISN. The vendor must keep track of the lot numbers and expiration dates for each reagent provided to the Boise VAMC Blood Bank. Since these reagents are made from cellular material, they expire quickly. The vendor should send the new lot number shortly before the old one expires to ensure the Blood Bank always has the necessary reagents for matching blood products. The vendor shall supply the Transfusion Service with red blood cells reagents that meet the current standards and/or regulations of the Food and Drug Administration (FDA), the College of American Pathologists (CAP), the Joint Commission (TJC), and the American Association of Blood Banks (AABB) to ensure patient safety.
-Solicitation11/18/2026
Please see attached Combined Synopsis/Solicitation. See attached estimated quantities and Questions and Answers.
-Combined Synopsis11/18/2026
Requesting procurement of a high-throughput FDA approved molecular diagnostic testing system and reagents through a rental purchase agreement. Purchase order is requested to order additional specific products throughout the year necessary to perform rapid syndromic infectious disease diagnostic panels.
-Market Research11/27/2026
-AwardedOpen

Additional Details

Solicitation Number

36C24919Q0036

Archive Date

Jan 6, 2019